News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Jul 14, 2023, 07:05

Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? – Paolo Tarantino

Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? In METEORA2, just published on JAMA Oncology by Elisabetta Munzone et al, VEX (VNR, endoxan, Xeloda) improved TTF and PFS over paclitaxel, with similar OS and at the cost of G3-4 tox.

https://jamanetwork.com/journals/jamaoncology/fullarticle/2807037

 

Source: Paolo Tarantino / Twitter

OncoDaily Oncology Paolo Tarantino Research
Special Coverage
Blog
May 21, 2025, 21:13
2025 Chinese Congress on Holistic Integrative Oncology (CCHIO)
Insight
May 21, 2025, 19:15
Haydeé Verduzco-Aguirre shared study on 20-year breast cancer trends and treatment gaps in São Paulo
Insight
May 21, 2025, 19:10
Samuel Hume: Top 5 advances in medicine this week
Insight
May 21, 2025, 19:04
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology
Career
May 21, 2025, 17:46
Sharon Kapambwe Has Been Appointed as Technical Officer for Cancer Control at WHO Uzbekistan
Opinion
May 21, 2025, 17:41
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study